HEADER TRANSFERASE/INHIBITOR 10-MAY-23 8STG TITLE DISCOVERY AND CLINICAL VALIDATION OF RLY-4008, THE FIRST HIGHLY TITLE 2 SELECTIVE FGFR2 INHIBITOR WITH ACTIVITY ACROSS FGFR2 ALTERATIONS AND TITLE 3 RESISTANCE MUTATIONS COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 458-769); COMPND 5 SYNONYM: FGFR-2,K-SAM,KGFR,KERATINOCYTE GROWTH FACTOR RECEPTOR; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFR2, BEK, KGFR, KSAM; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS RELAY INHIBITOR, CYTOSOLIC PROTEIN, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.VALVERDE,L.FOSTER REVDAT 6 25-OCT-23 8STG 1 REMARK REVDAT 5 18-OCT-23 8STG 1 REMARK LINK MTRIX ATOM REVDAT 4 20-SEP-23 8STG 1 COMPND HETNAM FORMUL ATOM REVDAT 3 13-SEP-23 8STG 1 JRNL REVDAT 2 14-JUN-23 8STG 1 JRNL REVDAT 1 07-JUN-23 8STG 0 JRNL AUTH V.SUBBIAH,V.SAHAI,D.MAGLIC,K.BRUDEREK,B.B.TOURE,S.ZHAO, JRNL AUTH 2 R.VALVERDE,P.J.O'HEARN,D.T.MOUSTAKAS,H.SCHONHERR, JRNL AUTH 3 N.GERAMI-MOAYED,A.M.TAYLOR,B.M.HUDSON,D.J.HOUDE,D.PAL, JRNL AUTH 4 L.FOSTER,H.GUNAYDIN,P.AYAZ,D.A.SHARON,L.GOYAL,A.M.SCHRAM, JRNL AUTH 5 S.KAMATH,C.A.SHERWIN,O.SCHMIDT-KITTLER,K.Y.JEN,F.RICARD, JRNL AUTH 6 B.B.WOLF,D.E.SHAW,D.A.BERGSTROM,J.WATTERS,J.B.CASALETTO JRNL TITL RLY-4008, THE FIRST HIGHLY SELECTIVE FGFR2 INHIBITOR WITH JRNL TITL 2 ACTIVITY ACROSS FGFR2 ALTERATIONS AND RESISTANCE MUTATIONS. JRNL REF CANCER DISCOV V. 13 2012 2023 JRNL REFN ESSN 2159-8290 JRNL PMID 37270847 JRNL DOI 10.1158/2159-8290.CD-23-0475 REMARK 2 REMARK 2 RESOLUTION. 3.79 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.79 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 56.30 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 7780 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.307 REMARK 3 R VALUE (WORKING SET) : 0.307 REMARK 3 FREE R VALUE : 0.311 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 389 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 56.3000 - 5.4700 1.00 2548 136 0.2828 0.3004 REMARK 3 2 5.4600 - 4.3400 1.00 2439 133 0.3195 0.3031 REMARK 3 3 4.3400 - 3.7900 1.00 2404 120 0.3467 0.3418 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.374 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 35.557 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 104.8 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 128.9 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 4548 REMARK 3 ANGLE : 0.733 6152 REMARK 3 CHIRALITY : 0.043 669 REMARK 3 PLANARITY : 0.007 780 REMARK 3 DIHEDRAL : 8.129 599 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8STG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-MAY-23. REMARK 100 THE DEPOSITION ID IS D_1000274372. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-SEP-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000032 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7810 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.787 REMARK 200 RESOLUTION RANGE LOW (A) : 56.305 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 9.560 REMARK 200 R MERGE (I) : 0.12300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.79 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.74200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3RI1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS, PH 8, 18-20% W/V PEG8000, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.25500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.81000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.67000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 64.81000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.25500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.67000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 453 REMARK 465 HIS A 454 REMARK 465 MET A 455 REMARK 465 GLY A 456 REMARK 465 SER A 457 REMARK 465 PRO A 458 REMARK 465 MET A 459 REMARK 465 LEU A 460 REMARK 465 GLY A 583 REMARK 465 MET A 584 REMARK 465 GLU A 585 REMARK 465 TYR A 586 REMARK 465 SER A 587 REMARK 465 TYR A 588 REMARK 465 ASP A 589 REMARK 465 ILE A 590 REMARK 465 ASN A 591 REMARK 465 ARG A 592 REMARK 465 LEU A 647 REMARK 465 ALA A 648 REMARK 465 ARG A 649 REMARK 465 ASP A 650 REMARK 465 ILE A 651 REMARK 465 ASN A 652 REMARK 465 ASN A 653 REMARK 465 ILE A 654 REMARK 465 ASP A 655 REMARK 465 TYR A 656 REMARK 465 TYR A 657 REMARK 465 LYS A 658 REMARK 465 LYS A 659 REMARK 465 THR A 660 REMARK 465 THR A 661 REMARK 465 ASN A 662 REMARK 465 GLY A 663 REMARK 465 THR A 765 REMARK 465 ASN A 766 REMARK 465 GLU A 767 REMARK 465 GLU A 768 REMARK 465 TYR A 769 REMARK 465 SER B 453 REMARK 465 HIS B 454 REMARK 465 MET B 455 REMARK 465 GLY B 456 REMARK 465 SER B 457 REMARK 465 PRO B 458 REMARK 465 MET B 459 REMARK 465 LEU B 460 REMARK 465 ALA B 461 REMARK 465 GLY B 462 REMARK 465 VAL B 463 REMARK 465 SER B 464 REMARK 465 GLU B 465 REMARK 465 TYR B 466 REMARK 465 GLU B 467 REMARK 465 LEU B 468 REMARK 465 PRO B 469 REMARK 465 GLU B 470 REMARK 465 ASP B 471 REMARK 465 GLY B 583 REMARK 465 MET B 584 REMARK 465 GLU B 585 REMARK 465 TYR B 586 REMARK 465 SER B 587 REMARK 465 TYR B 588 REMARK 465 ASP B 589 REMARK 465 ILE B 590 REMARK 465 ASN B 591 REMARK 465 ARG B 592 REMARK 465 ARG B 649 REMARK 465 ASP B 650 REMARK 465 ILE B 651 REMARK 465 ASN B 652 REMARK 465 ASN B 653 REMARK 465 ILE B 654 REMARK 465 ASP B 655 REMARK 465 TYR B 656 REMARK 465 TYR B 657 REMARK 465 LYS B 658 REMARK 465 ASN B 766 REMARK 465 GLU B 767 REMARK 465 GLU B 768 REMARK 465 TYR B 769 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 641 CG CD CE NZ REMARK 470 LYS A 724 CG CD CE NZ REMARK 470 ARG B 737 CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS B 491 H381 WCJ B 801 0.78 REMARK 500 SG CYS A 491 H381 WCJ A 801 1.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 466 26.26 -147.18 REMARK 500 LYS A 505 -13.68 78.97 REMARK 500 LYS A 509 -5.24 65.31 REMARK 500 ASP A 522 38.55 -92.66 REMARK 500 ASN A 546 56.62 -100.92 REMARK 500 THR A 555 -65.11 -97.79 REMARK 500 ASP A 557 66.00 63.43 REMARK 500 PRO A 594 -179.14 -65.94 REMARK 500 ASP A 644 4.11 90.77 REMARK 500 CYS B 491 -48.74 66.65 REMARK 500 PRO B 508 3.46 -67.42 REMARK 500 ASN B 546 51.81 -92.71 REMARK 500 ASP B 557 68.07 60.44 REMARK 500 ARG B 580 151.40 175.11 REMARK 500 ALA B 643 51.17 -146.69 REMARK 500 ASP B 644 99.26 -166.05 REMARK 500 ARG B 664 -15.79 71.23 REMARK 500 REMARK 500 REMARK: NULL DBREF 8STG A 458 769 UNP P21802 FGFR2_HUMAN 458 769 DBREF 8STG B 458 769 UNP P21802 FGFR2_HUMAN 458 769 SEQADV 8STG SER A 453 UNP P21802 EXPRESSION TAG SEQADV 8STG HIS A 454 UNP P21802 EXPRESSION TAG SEQADV 8STG MET A 455 UNP P21802 EXPRESSION TAG SEQADV 8STG GLY A 456 UNP P21802 EXPRESSION TAG SEQADV 8STG SER A 457 UNP P21802 EXPRESSION TAG SEQADV 8STG SER B 453 UNP P21802 EXPRESSION TAG SEQADV 8STG HIS B 454 UNP P21802 EXPRESSION TAG SEQADV 8STG MET B 455 UNP P21802 EXPRESSION TAG SEQADV 8STG GLY B 456 UNP P21802 EXPRESSION TAG SEQADV 8STG SER B 457 UNP P21802 EXPRESSION TAG SEQRES 1 A 317 SER HIS MET GLY SER PRO MET LEU ALA GLY VAL SER GLU SEQRES 2 A 317 TYR GLU LEU PRO GLU ASP PRO LYS TRP GLU PHE PRO ARG SEQRES 3 A 317 ASP LYS LEU THR LEU GLY LYS PRO LEU GLY GLU GLY CYS SEQRES 4 A 317 PHE GLY GLN VAL VAL MET ALA GLU ALA VAL GLY ILE ASP SEQRES 5 A 317 LYS ASP LYS PRO LYS GLU ALA VAL THR VAL ALA VAL LYS SEQRES 6 A 317 MET LEU LYS ASP ASP ALA THR GLU LYS ASP LEU SER ASP SEQRES 7 A 317 LEU VAL SER GLU MET GLU MET MET LYS MET ILE GLY LYS SEQRES 8 A 317 HIS LYS ASN ILE ILE ASN LEU LEU GLY ALA CYS THR GLN SEQRES 9 A 317 ASP GLY PRO LEU TYR VAL ILE VAL GLU TYR ALA SER LYS SEQRES 10 A 317 GLY ASN LEU ARG GLU TYR LEU ARG ALA ARG ARG PRO PRO SEQRES 11 A 317 GLY MET GLU TYR SER TYR ASP ILE ASN ARG VAL PRO GLU SEQRES 12 A 317 GLU GLN MET THR PHE LYS ASP LEU VAL SER CYS THR TYR SEQRES 13 A 317 GLN LEU ALA ARG GLY MET GLU TYR LEU ALA SER GLN LYS SEQRES 14 A 317 CYS ILE HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU VAL SEQRES 15 A 317 THR GLU ASN ASN VAL MET LYS ILE ALA ASP PHE GLY LEU SEQRES 16 A 317 ALA ARG ASP ILE ASN ASN ILE ASP TYR TYR LYS LYS THR SEQRES 17 A 317 THR ASN GLY ARG LEU PRO VAL LYS TRP MET ALA PRO GLU SEQRES 18 A 317 ALA LEU PHE ASP ARG VAL TYR THR HIS GLN SER ASP VAL SEQRES 19 A 317 TRP SER PHE GLY VAL LEU MET TRP GLU ILE PHE THR LEU SEQRES 20 A 317 GLY GLY SER PRO TYR PRO GLY ILE PRO VAL GLU GLU LEU SEQRES 21 A 317 PHE LYS LEU LEU LYS GLU GLY HIS ARG MET ASP LYS PRO SEQRES 22 A 317 ALA ASN CYS THR ASN GLU LEU TYR MET MET MET ARG ASP SEQRES 23 A 317 CYS TRP HIS ALA VAL PRO SER GLN ARG PRO THR PHE LYS SEQRES 24 A 317 GLN LEU VAL GLU ASP LEU ASP ARG ILE LEU THR LEU THR SEQRES 25 A 317 THR ASN GLU GLU TYR SEQRES 1 B 317 SER HIS MET GLY SER PRO MET LEU ALA GLY VAL SER GLU SEQRES 2 B 317 TYR GLU LEU PRO GLU ASP PRO LYS TRP GLU PHE PRO ARG SEQRES 3 B 317 ASP LYS LEU THR LEU GLY LYS PRO LEU GLY GLU GLY CYS SEQRES 4 B 317 PHE GLY GLN VAL VAL MET ALA GLU ALA VAL GLY ILE ASP SEQRES 5 B 317 LYS ASP LYS PRO LYS GLU ALA VAL THR VAL ALA VAL LYS SEQRES 6 B 317 MET LEU LYS ASP ASP ALA THR GLU LYS ASP LEU SER ASP SEQRES 7 B 317 LEU VAL SER GLU MET GLU MET MET LYS MET ILE GLY LYS SEQRES 8 B 317 HIS LYS ASN ILE ILE ASN LEU LEU GLY ALA CYS THR GLN SEQRES 9 B 317 ASP GLY PRO LEU TYR VAL ILE VAL GLU TYR ALA SER LYS SEQRES 10 B 317 GLY ASN LEU ARG GLU TYR LEU ARG ALA ARG ARG PRO PRO SEQRES 11 B 317 GLY MET GLU TYR SER TYR ASP ILE ASN ARG VAL PRO GLU SEQRES 12 B 317 GLU GLN MET THR PHE LYS ASP LEU VAL SER CYS THR TYR SEQRES 13 B 317 GLN LEU ALA ARG GLY MET GLU TYR LEU ALA SER GLN LYS SEQRES 14 B 317 CYS ILE HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU VAL SEQRES 15 B 317 THR GLU ASN ASN VAL MET LYS ILE ALA ASP PHE GLY LEU SEQRES 16 B 317 ALA ARG ASP ILE ASN ASN ILE ASP TYR TYR LYS LYS THR SEQRES 17 B 317 THR ASN GLY ARG LEU PRO VAL LYS TRP MET ALA PRO GLU SEQRES 18 B 317 ALA LEU PHE ASP ARG VAL TYR THR HIS GLN SER ASP VAL SEQRES 19 B 317 TRP SER PHE GLY VAL LEU MET TRP GLU ILE PHE THR LEU SEQRES 20 B 317 GLY GLY SER PRO TYR PRO GLY ILE PRO VAL GLU GLU LEU SEQRES 21 B 317 PHE LYS LEU LEU LYS GLU GLY HIS ARG MET ASP LYS PRO SEQRES 22 B 317 ALA ASN CYS THR ASN GLU LEU TYR MET MET MET ARG ASP SEQRES 23 B 317 CYS TRP HIS ALA VAL PRO SER GLN ARG PRO THR PHE LYS SEQRES 24 B 317 GLN LEU VAL GLU ASP LEU ASP ARG ILE LEU THR LEU THR SEQRES 25 B 317 THR ASN GLU GLU TYR HET WCJ A 801 63 HET WCJ B 801 63 HETNAM WCJ N-{4-[(5P)-4-AMINO-5-{3-FLUORO-4-[(4-METHYLPYRIMIDIN-2- HETNAM 2 WCJ YL)OXY]PHENYL}-7-METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-6- HETNAM 3 WCJ YL]PHENYL}-2-METHYLPROPANAMIDE FORMUL 3 WCJ 2(C28 H26 F N7 O2) HELIX 1 AA1 THR A 524 GLY A 542 1 19 HELIX 2 AA2 ASN A 571 ARG A 579 1 9 HELIX 3 AA3 THR A 599 GLN A 620 1 22 HELIX 4 AA4 PRO A 666 MET A 670 5 5 HELIX 5 AA5 ALA A 671 ARG A 678 1 8 HELIX 6 AA6 THR A 681 THR A 698 1 18 HELIX 7 AA7 PRO A 708 GLU A 718 1 11 HELIX 8 AA8 THR A 729 TRP A 740 1 12 HELIX 9 AA9 THR A 749 THR A 762 1 14 HELIX 10 AB1 PRO B 477 LEU B 481 5 5 HELIX 11 AB2 THR B 524 GLY B 542 1 19 HELIX 12 AB3 ASN B 571 ARG B 579 1 9 HELIX 13 AB4 THR B 599 GLN B 620 1 22 HELIX 14 AB5 PRO B 666 MET B 670 5 5 HELIX 15 AB6 ALA B 671 PHE B 676 1 6 HELIX 16 AB7 THR B 681 THR B 698 1 18 HELIX 17 AB8 PRO B 708 GLU B 718 1 11 HELIX 18 AB9 THR B 729 TRP B 740 1 12 HELIX 19 AC1 THR B 749 THR B 762 1 14 SHEET 1 AA1 5 LEU A 483 PRO A 486 0 SHEET 2 AA1 5 VAL A 495 VAL A 501 -1 O MET A 497 N LYS A 485 SHEET 3 AA1 5 ALA A 511 LYS A 517 -1 O VAL A 512 N ALA A 500 SHEET 4 AA1 5 TYR A 561 VAL A 564 -1 O VAL A 564 N ALA A 515 SHEET 5 AA1 5 LEU A 550 CYS A 554 -1 N LEU A 551 O ILE A 563 SHEET 1 AA2 2 VAL A 632 VAL A 634 0 SHEET 2 AA2 2 MET A 640 ILE A 642 -1 O LYS A 641 N LEU A 633 SHEET 1 AA3 4 VAL B 495 VAL B 501 0 SHEET 2 AA3 4 ALA B 511 LYS B 517 -1 O VAL B 512 N ALA B 500 SHEET 3 AA3 4 TYR B 561 VAL B 564 -1 O VAL B 564 N ALA B 515 SHEET 4 AA3 4 LEU B 550 CYS B 554 -1 N CYS B 554 O TYR B 561 SHEET 1 AA4 2 CYS B 622 ILE B 623 0 SHEET 2 AA4 2 GLY B 646 LEU B 647 -1 O GLY B 646 N ILE B 623 SHEET 1 AA5 2 VAL B 632 VAL B 634 0 SHEET 2 AA5 2 MET B 640 ILE B 642 -1 O LYS B 641 N LEU B 633 LINK SG CYS A 491 C38 WCJ A 801 1555 1555 1.93 LINK SG CYS B 491 C38 WCJ B 801 1555 1555 1.88 CRYST1 62.510 91.340 129.620 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015997 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010948 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007715 0.00000